Literature DB >> 5004179

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.

E Haupt, W Köberich, J Beyer, K Schöffling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5004179     DOI： 10.1007/bf01212062

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  A simplified method for immuno-assay of human serum insulin.

Authors:  R C MEADE; H M KLITGAARD
Journal:  J Nucl Med       Date:  1962-09       Impact factor: 10.057

2.  [Mechanism of action of hypoglycemic sulfonyl urea compounds, D 860 & BZ 55].

Authors:  A BANDER
Journal:  Dtsch Med Wochenschr       Date:  1959-05-22       Impact factor: 0.628

3.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

Review 4.  [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1969-09

5.  Dynamics of insulin secretion by the perfused rat pancreas.

Authors:  D L Curry; L L Bennett; G M Grodsky
Journal:  Endocrinology       Date:  1968-09       Impact factor: 4.736

6.  [Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system].

Authors:  G M Grodsky; D Curry; H Landahl; L Bennett
Journal:  Acta Diabetol Lat       Date:  1969-09

7.  [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors:  H Mehnert; E Karg
Journal:  Dtsch Med Wochenschr       Date:  1969-04-18       Impact factor: 0.628

8.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

9.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

10.  [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].

Authors:  A Loubatières; M M Mariani; G Ribes; H de Malbosc; J Chapal
Journal:  Diabetologia       Date:  1969-02       Impact factor: 10.122
  10 in total
  9 in total

1.  [Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)].

Authors:  E Haupt; K A Küllmer; K Schöffling
Journal:  Klin Wochenschr       Date:  1977-07-15

2.  Metabolic effects of fenfluramine in obese diabetics.

Authors:  S Larsen; L Vejtorp; P Hornnes; H Bechgaard; L Sestoft; J Lyngsoe
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.

Authors:  M M Loubatières-Mariani; A L Loubatières; J Chapal
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

4.  [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].

Authors:  K Schöffling; E Haupt; W Köberich; J Beyer
Journal:  Klin Wochenschr       Date:  1973-01-15

Review 5.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

7.  Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.

Authors:  P Heine; H Kewitz; U Schnapperelle
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

8.  [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].

Authors:  W Beischer; S Raptis; L Keller; M Maas; B Beischer; K Feilen; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1978-02-01

9.  Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.

Authors:  C F Gotfredsen
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.